首页> 外文期刊>The Open Anesthesiology Journal >Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prevention of Atrial Fibrillation After On-Pump Coronary Artery Bypass Graft Surgery
【24h】

Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prevention of Atrial Fibrillation After On-Pump Coronary Artery Bypass Graft Surgery

机译:比索洛尔与皮质类固醇和比索洛尔的组合可预防泵上冠状动脉搭桥手术后的房颤

获取原文
           

摘要

Background: The most common cardiac arrhythmia that happens after on-pump Coronary Artery Bypass Graft (CABG) surgery is Atrial Fibrillation (AF). It is combined with several postoperative complications such as increased incidence of stroke, increased hospital stay and increased costs. Objectives: The aim of this study was to look for safe, effective, reliable and well tolerated tools for the prevention of atrial fibrillation after on pump coronary artery bypass surgery. Patients and Methods: The study enclosed 176 patients (the age ranges from 40 to 79 years) and scheduled for elective on-pump CABG operations without concomitant procedures. The patients were selected randomly into two equal groups. Group (A) in which bisoprolol was used to prevent atrial fibrillation after surgery. Group (B) in which bisoprolol and hydrocortisone were used for prevention of atrial fibrillation after surgery. For each patient, the following data were collected: gender, preoperative diseases, cardiopulmonary bypass time, intraoperative cross clamp time, Left internal mammary Artery usage, incidence of postoperative atrial fibrillation, death, myocardial infarction chest infection and C-reactive protein amount in plasma. Results: There was a statistically significant decrease in the occurrence of atrial fibrillation in group (B) when compared to corresponding values in group (A). Also, group (B) showed a statistically significant decrease in length of hospital stay in comparison to group (A). C-reactive protein concentrations on the 1st and 2nd postoperative days were lower significantly in group (B) than in group (A). There were no statistically significant differences between both groups regarding gender, preoperative diseases, cardiorespiratory bypass time, intraoperative cross clamp time, Left internal mammary artery usage, death, myocardial infarction and chest infection. Conclusion: This study demonstrated that using bisoprolol and hydrocortisone combination showed greater benefit than the use of bisoprolol only for prevention of postoperative AF after on-pump coronary artery bypass graft surgery.
机译:背景:泵上冠状动脉旁路移植术(CABG)手术后发生的最常见的心律不齐是房颤(AF)。并伴有多种术后并发症,例如中风发生率增加,住院时间增加和费用增加。目的:本研究的目的是寻找安全,有效,可靠且耐受性良好的工具,以防止在进行冠状动脉搭桥手术后发生心房纤颤。患者和方法:该研究纳入了176例患者(年龄在40至79岁之间),并计划在无伴随程序的情况下进行选择性泵上CABG手术。将患者随机分为两组。 (A)组,其中比索洛尔用于预防术后房颤。 (B)组,其中使用比索洛尔和氢化可的松预防术后的房颤。为每位患者收集以下数据:性别,术前疾病,体外循环时间,术中交叉钳夹时间,左内乳动脉使用情况,术后房颤发生率,死亡,心肌梗塞胸部感染和血浆C反应蛋白含量。结果:与(A)组的相应值相比,(B)组的房颤发生率有统计学意义的降低。此外,与组(A)相比,组(B)的住院时间在统计学上有显着减少。术后第一天和第二天的C反应蛋白浓度显着低于(A)组。两组在性别,术前疾病,心肺搭桥时间,术中交叉钳夹时间,左乳内动脉使用,死亡,心肌梗塞和胸部感染方面无统计学差异。结论:这项研究表明,比索洛尔和氢可的松联合使用比仅比索洛尔在预防泵上冠状动脉搭桥术术后房颤中具有更大的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号